David Foxe with FTD study participant

FTD & Alzheimer's disease



The Frontier team is currently recruiting healthy adults, aged 50 years and over, for research aiding the diagnosis and treatment of dementia syndromes including frontotemporal dementia and Alzheimer’s disease. Our group examines the cognitive, behavioural, psychological, and brain changes in individuals with dementia and measures their impact on patients and their families. Our group is also studying how changes in dementia differ from those seen in other brain disorders and in healthy ageing, to help improve the diagnosis of dementia.

As part of this research, we require healthy volunteers to act as a comparison group. Participation in this study can involve a number of different tests of memory, language and other thinking abilities. We may also ask to take a blood sample, and an MRI brain scan may be offered. This all takes place at the NeuRA institute (any travelling costs will be reimbursed).

If you are interested, or for more information, please contact frontier@neura.edu.au

See what’s going on at NeuRA


'I've got the best job for you dad. Your shaky arm will be perfect for it!'

Children… honest and insightful. Their innocence warms the heart. But what words do you use to explain to a child that daddy has an incurable brain disease? What words tell them that in time he may not be able to play football in the park, let alone feed himself? What words help them understand that in the later stages, dementia may also strike? Aged just 36, this was the reality that faced Steve Hartley. Parkinson's disease didn't care he was a fit, healthy, a young dad and devoted husband. It also didn't seem to care his family had no history of it. The key to defeating Parkinson's disease is early intervention, and thanks to a global research team, led by NeuRA, we're pleased to announce that early intervention may be possible. Your support, alongside national and international foundations Shake it Up Australia and the Michael J Fox Foundation, researchers have discovered that a special protein, found in people with a family history of the disease increases prior to Parkinson’s symptoms developing. This is an incredible step forward, because it means that drug therapies, aimed at blocking the increase in the protein, can be administered much earlier – even before symptoms strike. The next step is to understand when to give the drug therapies and which people will most benefit from it. But we need your help. A gift today will support vital research and in time help medical professionals around the world treat Parkinson’s disease sooner, with much better health outcomes. Thank you, in advance, for your support.